Enfanos Announces Agreement with Waters to Advance Mass Spectrometry Solutions for Newborn Screening Research and Applications Agreement underscores Enfanos’ dedication to advancing scientific discovery and supporting the newborn screening community. Enfanos announced a co-marketing agreement with Waters Corporation , a global leader in mass spectrometry technologies. This agreement enables Enfanos to seamlessly connect innovative enzyme activity and biomarker assay products,

New qNMR Quantified Biomarker standards are now available from Enfanos!

New Biomarker QC DBS are now available from Enfanos!

GelbChem is excited to introduce a suite of products in support of implementation of ARSA Deficiency Assays! Products are for research...

We are excited to be presenting our newest Enzyme Activity Assay for newborn screening of Tay-Sachs and Sandhoff diseases at the 2024...

We at GelbChem are thrilled to supply the majority of enzyme activity and biomarker assay reagents for the ScreenPlus Pilot Study in...

The results are in! See the International Journal of Neonatal Screening article at the following link: https://www.mdpi.com/2409-515X/6/...